Skip to main content
Equibles
PGNY logo

PGNY · Progyny, Inc. · Metrics

Track PGNY — free

Use PGNY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PGNY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$29.13 +0.69 (+2.43%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.18B
Shares
76.73M
Volume · Oct 22 233.91K Avg daily vol (3M) 1.13M

PGNY metrics

97 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$28.44
Market cap
$2.18B

Price action

20 metrics
Price change (1W)
+2.2%
Price change (30D)
+8.4%
Price change (3M)
-9.3%
Price change (6M)
+58.1%
Price change (YTD)
+10.7%
Price change (1Y)
+46.5%
Trailing year
Price change (5Y)
-53.6%
52-week high
$32.36
52-week low
$16.30
Change from 52-week high
-12.1%
Change from 52-week low
+74.5%
Annualized volatility
54.3%
Annualized volatility (3M)
35.8%
Beta
0.4
RSI (14D)
60.8
Price vs SMA 50
+7.4%
Price vs SMA 200
+17.0%
Avg volume (3M)
1.13M
Relative volume
0.6
Average dollar volume
$30.79M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
76.73M

Valuation

12 metrics
P / E (TTM)
30.9
Trailing earnings · reciprocal yield 3.2%
PEG ratio
0.4
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.7×
reciprocal yield 60.1%
P / book
4.8
reciprocal yield 20.8%
FCF yield
8.2%
TTM · current market cap
Buyback yield
10.6%
P / FCF
12.2
reciprocal yield 8.2%
P / operating cash flow
10.8
reciprocal yield 9.2%
Earnings yield
3.6%

Historical valuation

8 metrics
P / E historical average (3Y)
38.3×
reciprocal yield 2.6%
P / E historical average (5Y)
57.3×
reciprocal yield 1.7%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
10.6%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
24.6%
Operating margin
8.6%
Trailing 12 months
Net margin
6.0%
Gross profit (TTM)
$322.09M
Operating profit (TTM)
$112.13M
Net income (TTM)
$78.63M
Trailing 12 months
Diluted EPS (TTM)
$0.92
FCF margin
13.6%
Effective tax rate
34.4%

Per share

11 metrics
Revenue per diluted share (TTM)
$15.17
Gross profit per diluted share (TTM)
$3.73
Operating profit per diluted share (TTM)
$1.31
EBITDA per diluted share (TTM)
$1.38
Net income per diluted share (TTM)
$0.92
Operating cash flow per diluted share (TTM)
$2.32
Free cash flow per diluted share (TTM)
$2.06
Capital expenditures per diluted share (TTM)
$0.27
R&D per diluted share (TTM)
$0.14
Stock compensation per diluted share (TTM)
$1.23
Book value per share
$6.19

Growth

11 metrics
Revenue growth YoY
+5.3%
Year over year
Net income growth YoY
+63.9%
Revenue (TTM)
$1.31B
Trailing 12 months
EPS growth YoY
+78.9%
Shares change YoY
-8.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+17.9%
Revenue CAGR (5Y)
+30.2%
EPS CAGR (3Y)
+29.4%
EPS CAGR (5Y)
+6.7%
FCF CAGR (3Y)
+35.5%
FCF CAGR (5Y)
+40.4%

Quality

14 metrics
Return on equity
17.3%
Return on assets
11.0%
Debt / equity
—
Current ratio
2.1
EBITDA (TTM)
$117.87M
Free cash flow (TTM)
$178.38M
Quick ratio
2.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$152.63M
Total assets
$715.84M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$201.25M
Capital expenditures (TTM)
$22.86M
R&D (TTM)
$11.80M
SG&A (TTM)
—
Stock compensation (TTM)
$107.17M
R&D / revenue
0.9%
Stock compensation / revenue
8.2%

Ownership (13F)

9 metrics
13F filers
312
13F filer change QoQ
+17
Institutional ownership
102.8%
Conviction holders (share of 13F filers)
0.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+0.1%
Holder tenure
13.0
Price vs estimated holder cost
+20.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
27.9%

Short interest

3 metrics
Short interest
6.6%
Latest settlement · 4.1 days to cover
Days to cover
4.1d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$413,726
Insider-sentiment score
44 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1551306 CUSIP 74340E103 13F (30d) 34 filings 34 filers Visit website Investor relations